Merck & Co. Inc. (MRK) News

Merck & Co. Inc. (MRK): $92.42

1.25 (+1.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter MRK News Items

MRK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MRK News Highlights

  • For MRK, its 30 day story count is now at 67.
  • Over the past 25 days, the trend for MRK's stories per day has been choppy and unclear. It has oscillated between 1 and 15.
  • The most mentioned tickers in articles about MRK are DRUG, AG and BEAT.

Latest MRK News From Around the Web

Below are the latest news stories about Merck & Co Inc that investors may wish to consider to help them evaluate MRK as an investment opportunity.

Iovance (IOVA) Announces Wider-Than-Anticipated Q4 Loss

Iovance Biotherapeutics' (IOVA) fourth-quarter loss is wider than expected. The company is on track to file regulatory submission for lifileucel in melanoma by first-half 2022.

Yahoo | February 25, 2022

10 Stocks to Invest In According to Bart Baum’s Ionic Capital

In this article, we discuss 10 stocks to invest in according to Bart Baum’s Ionic Capital. If you want to skip our detailed analysis of Baum’s history, investment philosophy, and hedge fund performance, go directly to 5 Stocks to Invest In According to Bart Baum’s Ionic Capital. Bart Baum holds a bachelor’s degree in political science […]

Yahoo | February 25, 2022

Merck & Co. Is Honored to Be Named to Forbes America's Best Employers List for the Eighth Year in a Row.

We are honored to have been named to Forbes America's Best Employers list for the eighth year in a row! We were ranked in the top 50 of Overall Best Large Companies this year, and we were ranked se...

Yahoo | February 25, 2022

This Is What Whales Are Betting On Merck & Co

Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE: MRK ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don''t know. But when something this big happens with MRK, it often means somebody knows something is about to happen. So how do we know what this whale just did? Today, Benzinga ''s options scanner spotted 17 uncommon options trades for Merck & Co. This isn''t normal. The overall sentiment of these big-money traders is split between 29% bullish and 70%, bearish. Out of all of the special options we uncovered, 4 are puts, for a total amount of $134,404, and 13 are calls, for a tot...

Benzinga | February 24, 2022

How companies like Merck and CVS Health are tackling the leaky P&L pipeline

Profit and loss experience is critical to career development, and Paradigm for Parity is launching a program aiming to close that gap for women of color. Read More

Fortune | February 24, 2022

PDS Biotech Announces Preliminary Safety Data on PDS0101 in Combination With KEYTRUDA® (pembrolizumab) at the 2022 Multidisciplinary Head and Neck Cancers Symposium

Preliminary safety data has shown that PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA ® (pembrolizumab) for the treatment of recurrent or metastatic HPV16-positive head and neck cancer is likely safe and well tolerated without evidence of enhanced or significant toxicity

GlobeNewswire | February 24, 2022

Moderna (MRNA) Q4 Earnings Top, COVID-19 Vaccine Brings $7B

Moderna's (MRNA) COVID-19 vaccine sales beat expectations. The company delivers 297 million doses of its COVID-19 vaccine during the fourth quarter. Stock gains in pre-market.

Yahoo | February 24, 2022

10 Best Dividend Stocks to Buy According to Kahn Brothers

In this article, we discuss the 10 best dividend stocks to buy according to Kahn Brothers. You can skip our detailed analysis of the hedge fund’s investment philosophy, and go directly to read 5 Best Dividend Stocks to Buy According to Kahn Brothers. Kahn Brothers Group, an investment management firm, was founded by Irving Kahn, […]

Yahoo | February 24, 2022

Merck Came Into Today Down -0.55%

Read more Merck Came Into Today Down -0.55% The post Merck Came Into Today Down -0.55% appeared first on CFDTrading .

CFDTrading | February 23, 2022

Why This New Dad Says Every Company Should Offer Parental Leave

Our colleague says taking time off to bond with his daughter was the ‘right thing to do’ for his family

Yahoo | February 23, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6962 seconds.